Adenylosuccinic acid (tetraammonium)
Selected Variant
HY-127137A-01
Size: 5 mg
Adenylosuccinic acid tetraammonium (Adenylosuccinate; Aspartyl adenylate) is an orally active purine ribonucleoside monophosphate and plays a role in nucleotide cycle metabolite. Adenylosuccinic acid tetraammonium can be converted into fumaric acid through adenylosuccinate lyase. Adenylosuccinic acid tetraammonium has the potential for the study of duchenne muscular dystrophy (DMD) [1].
Product Specifications
Product Name Alternative
Adenylosuccinate (tetraammonium) ; Aspartyl adenylate (tetraammonium)
UNSPSC
12352005
Target
Endogenous Metabolite
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Purity
99.62
Solubility
H2O : 200 mg/mL (ultrasonic)
Smiles
O=C(C[C@H](NC1=C2N=CN(C2=NC=N1)[C@H]3[C@H](O)[C@H](O)[C@H](O3)COP(O)(O)=O)C(O)=O)O.N.N.N.N
Molecular Formula
C14H30N9O11P
Molecular Weight
531.42
References & Citations
[1]Timpani CA, et al. Adenylosuccinic acid tetraammonium therapy ameliorates murine Duchenne Muscular Dystrophy.Sci Rep. 2020 Jan 24;10 (1) :1125.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Isoform
Human Endogenous Metabolite
Available Sizes
Price
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
NKX2.2 (Neuroendocrine & Ewing's Sarcoma Marker), 0.2mg/mL
Spectrin beta III (SPTBN2) (SPTBN2/2979R), CF640R conjugate, 0.1mg/mL
CD137, Mouse (LOB12), CF647 conjugate, 0.1mg/mL
